HIMS — Hims & Hers Health, Inc. stock price, charts and financials

QT40Hims & Hers Health, Inc.

Hims & Hers Health, Inc. (NYSE: HIMS) is a Healthcare company in the Medical - Equipment & Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
31.64
+0.05+0.17%
OverviewShort InterestFilings
HIMSQT40Hims & Hers Health, Inc.·NYSE
31.64+0.17%
TA
Loading chart...
Signal & projected range
Short-squeeze setupHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
OMCL+0.46%$36.98DRTS+2.44%$13.46MLAB-0.30%$102.34LAB-2.50%$0.78TEM+6.54%$55.45NUVL+0.00%$123.96AVTR+0.70%$13.69RGEN-0.45%$163.16
Snapshot
Index-P/E-EPS (ttm)-0.09Insider Own3.03%Shs Outstand223.08MPerf Week13.76%
Market Cap7.05BForward P/E67.17EPS next Y0.47Insider Trans-4.17%Shs Float208.82MPerf Month-10.89%
Enterprise Value7.96BPEG5.92EPS next Q-Inst Own-Short Float29.41%Perf Quarter23.16%
Income-12.68MP/S2.97EPS this Y-39.90%Inst Trans-Short Ratio2.56Perf Half Y34.54%
Sales2.37BP/B16.17EPS next Y473.54%ROA-0.58%Short Interest61.41MPerf YTD-2.71%
Book/sh-P/C25.43EPS next 5Y-ROE-2.48%52W High65.41 -51.62%Perf Year-38.22%
Cash/sh-P/FCF92.92EPS past 3/5Y-ROIC0.66%52W Low13.76 129.91%Perf 3Y276.97%
Dividend Est.-EV/EBITDA-Sales past 3/5Y64.55% 73.58%Gross Margin67.64%Volatility6.80% 8.53%Perf 5Y299.37%
Dividend TTM-EV/Sales3.36EPS Y/Y TTM-116.98%Oper. Margin1.32%ATR (14)2.64Perf 10Y-
Dividend Ex-Date-Quick Ratio1.55Sales Y/Y TTM60.46%Profit Margin-0.56%RSI (14)51.02Recom2.65
Dividend Gr. 3/5Y-Current Ratio1.69EPS Q/Q-300.00%SMA200.86%Beta2.40Target Price26.91
Payout0.00%Debt/Eq2.54Sales Q/Q3.75%SMA500.47%Rel Volume0.45Prev Close31.59
Employees2,442LT Debt/Eq2.06EarningsAug 10SMA2006.25%Avg Volume18.51MPrice31.64
IPO DateSep 13, 2019Option/ShortYes / YesEPS/Sales Surpr.-1676.48% -1.42%Net Debt/EBITDA30.27Volume8,246,312Change0.17%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-09-26ReiteratedUBS$25 → $37
Jul-01-26ReiteratedCanaccord GenuityBuy$32 → $40
Jun-02-26ReiteratedLeerink PartnersMarket Perform$18 → $25
May-26-26ReiteratedUBS$23 → $25
May-22-26ReiteratedUBS$18 → $23
May-12-26ReiteratedJefferiesHold$26 → $25
May-12-26ReiteratedUBS$30 → $35
May-12-26ReiteratedCanaccord GenuityBuy$30 → $32
May-05-26ReiteratedDeutsche BankHold$28 → $25
Mar-10-26ReiteratedDeutsche BankHold$31 → $28
Latest News
Today
Today10:15AM
Kaplan Fox & Kilsheimer LLP Encourages Hims & Hers Health, Inc. (HIMS) Investors to Contact the Firm Regarding Potential Securities Law Violationsnewsfilecorp.com
Aug-09-26
Aug-09-2605:22PM
HIMS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firmglobenewswire.com
Aug-07-26
Aug-07-2603:07PM
HIMS & HERS HEALTH INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Hims & Hers Health, Inc. on Behalf of Hims & Hers Stockholders and Encourages Investors to Contact the Firmglobenewswire.com
02:56PM
Can Weight-Loss Momentum Lift Hims & Hers Stock Before Q2 Earnings?zacks.com
09:00AM
Kaplan Fox Notifies Hims & Hers Health, Inc. (HIMS) Investors of a Securities Investigation into the Companynewsfilecorp.com
Aug-06-26
Aug-06-2601:50PM
CareCloud, Inc. (CCLD) Lags Q2 Earnings and Revenue EstimatesYahoo
12:22PM
Lowey Dannenberg, P.C. is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Violations of the Federal Securities Lawsglobenewswire.com
09:00AM
Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experiencebusinesswire.com
Aug-05-26
Aug-05-2608:00PM
HIMS & HERS HEALTH, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraudglobenewswire.com
06:45PM
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investorszacks.com
03:06PM
NYSE: HIMS Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firmprnewswire.com
11:00AM
Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firmglobenewswire.com
09:51AM
Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (HIMS)newsfilecorp.com
09:00AM
Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Continuing Securities Fraud Investigationglobenewswire.com
Aug-04-26
Aug-04-2607:02PM
NYSE: HIMS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firmglobenewswire.com
Company

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue2,3702,3481,477—————
Cost of Goods Sold Incl. D&A767614303—————
Gross Profit1,6021,7331,173—————
Selling, General and Administrative Excl. Other1,2441,192847—————
Research and Development16714979—————
Other Operating Expense160287185—————
Operating Income3210662—————
Interest Expense
000—————
Unusual Expense
————————
Non-Operating Income (Expense)-701810—————
Net Income Before Taxes-3912472—————
Income Taxes-25-4-54—————
Consolidated Net Income-12128126—————
Net Income From Continuing Operations-12128126—————
Net Income-12128126—————
EPS (Recurring)-0.050.570.58—————
EPS (Basic, Before Extraordinaries)-0.050.570.58—————
EPS (Diluted)-0.090.510.53—————
EBITDA2917889—————
Other After Tax Adjustments
————————
Stock Option Compensation Expense
————————
Price To Earnings Ratio—63.6745.62—————
Price To Sales Ratio3.043.113.54—————
Gross Margin67.5973.8179.42—————
Operating Margin1.354.514.20—————
Net Margin-0.515.458.53—————
Shares Outstanding228225216—————
Market Capitalization7,2157,3065,223—————
Operating Lease Expense
————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$73.93$57.14$40.35$23.56$6.77● Close Price0.00M5.36M10.71M16.07M21.42MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Okupe OluyemiChief Financial OfficerJul 17 '26Sale31.997,163229,168284,321Jul 20
Okupe OluyemiChief Financial OfficerJul 17 '26Option Exercise5.017,16335,887291,484Jul 20
Okupe OluyemiChief Financial OfficerJul 06 '26Sale36.497,163261,351284,321Jul 07
Okupe OluyemiChief Financial OfficerJul 06 '26Option Exercise5.017,16335,887291,484Jul 07
Okupe OluyemiChief Financial OfficerJun 22 '26Option Exercise5.016,37631,944302,518Jun 23
Okupe OluyemiChief Financial OfficerJun 22 '26Sale34.0318,197619,217284,321Jun 23
Carroll Patrick HarrisonChief Medical OfficerJun 18 '26Sale35.0023,726830,410181,861Jun 23
Elshenawy MohamedCTOJun 17 '26Sale31.5030,040946,260101,023Jun 17
Chi MichaelChief Operating OfficerJun 17 '26Sale31.5014,027441,851432,124Jun 17
Becklund IrenePAOJun 17 '26Sale31.504,490141,4356,790Jun 17
Becklund IrenePAOJun 16 '26Sale30.257,573229,08311,280Jun 17
Okupe OluyemiChief Financial OfficerJun 15 '26Option Exercise0.00143,2320335,683Jun 17
Autor Deborah M.Chief Policy OfficerJun 15 '26Option Exercise0.0032,919064,357Jun 17
Chi MichaelChief Operating OfficerJun 15 '26Option Exercise0.00172,5280493,850Jun 17
Becklund IrenePAOJun 15 '26Option Exercise0.0031,942058,197Jun 17
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.